GENinCode (LON:GENI) Hits New 12-Month Low – Time to Sell?

GENinCode Plc (LON:GENIGet Free Report)’s share price reached a new 52-week low on Thursday . The stock traded as low as GBX 2.80 ($0.04) and last traded at GBX 2.89 ($0.04), with a volume of 780181 shares traded. The stock had previously closed at GBX 2.95 ($0.04).

GENinCode Stock Performance

The company’s 50 day simple moving average is GBX 3.66 and its 200 day simple moving average is GBX 4.21. The company has a debt-to-equity ratio of 9.28, a quick ratio of 15.89 and a current ratio of 2.60. The stock has a market cap of £5.13 million, a PE ratio of -0.84 and a beta of 0.66.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Read More

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.